Laxmi Organic Industries Ltd. Share Price

Laxmi Organic Industries in Focus After CEO Transition News

Laxmi Organic Industries stock may remain in focus on September 9 after Rajan Venkatesh resigned as MD & CEO. Harshvardhan Goenka will take charge from November 14, 2026. Laxmi Organic Industries Ltd. (NSE:

) is likely to remain in focus in today’s trading session, September 9, 2026, following a key leadership change announced by the company. Rajan Venkatesh has resigned as Managing Director and Chief Executive Officer (MD & CEO), effective November 13, 2026, to pursue opportunities outside the company. The Board has appointed Executive Director Harshvardhan Goenka as the new MD & CEO for a five-year term, effective November 14, 2026. The development comes as the stock has faced pressure over the past year. LXCHEM closed at ₹184.52 on September 8, 2026, down more than 19% over the last one year. The stock currently trades within a 52-week range of ₹108–₹241. Laxmi Organic Industries operates in acetyl and specialty intermediates, serving pharmaceuticals, agrochemicals, paints, and other industries. Investors may track management commentary and the market’s reaction to the leadership transition in today’s session. 📌 Disclaimer: This content is for information only and not investment advice. Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Please consult a SEBI-registered advisor before making any investment decisions.

See More

Update for Investors of

is currently trading at Rs. 202.70, up by 0.95 points or 0.47% from its previous closing of Rs. 201.75 on the BSE. The scrip opened at Rs. 202.30 and has touched a high and low of Rs. 203.95 and Rs. 201.50 respectively. So far 21305 shares were traded on the counter. Last one week high and low of the scrip stood at Rs. 208.75 and Rs. 199.45 respectively. The current market cap of the company is Rs. 5594.23 crore. The promoters holding in the company stood at 69.35%, while Institutions and Non-Institutions held 4.80% and 25.85% respectively. Laxmi Organic Industries has received the Consent to Operate (CTO) from the Gujarat Pollution Control Board (GPCB) for the first phase of its Synthetic Organic Chemicals manufacturing facility situated at Dahej, Village Jolve and Vadadala, District Bharuch, Gujarat (Dahej Site). Consequent to the receipt of the CTO, the company has successfully commissioned this first phase at the Dahej Site. Further, the company has also successfully dispatched its first shipment of products from the Dahej Site, marking a significant milestone in the commencement of commercial operations. Going forward, the Company’s primary focus over the next few months will be to operationalise the entire Dahej Site in a phased manner, while ensuring seamless stabilisation of operations with the highest standards of safety, efficiency, and quality. Laxmi Organic Industries is a leading manufacturer of Acetyl Intermediates and Specialty Intermediates. Laxmi Organic Industries rises on getting CTO for Dahej site Consequent to the receipt of the CTO, the company has successfully commissioned this first phase at the Dahej Site Laxmi Organic Industries is currently trading at Rs. 202.70, up by 0.95 points or 0.47 % from its previous closing of Rs. 201.75 on the BSE. The scrip opened at Rs. 202.30 and has touched a high and low of Rs. 203.95 and Rs. 201.50 respectively. So far 21305 shares were traded on the counter

See More

SWOT Analysis

Laxmi Organics – Latest Updates Business Overview Laxmi Organics is a specialty chemicals company focused on acetyl intermediates and diketene derivatives. Its products are used in pharma, agrochemicals, dyes, coatings, and packaging. Stock Performance Currently trades around ₹210–₹215. 52-week range: approx. ₹160 (low) to ₹325 (high). Market capitalization is in the ₹6,000+ crore range. Valuations are expensive with a high P/E multiple compared to peers. Financial Performance Recent quarterly results showed a sharp decline in profits, with earnings nearly halving year-on-year. Margins have been under pressure due to higher input costs and weaker realizations. For FY25, revenues grew modestly but profits declined. Corporate Developments Raised about ₹259 crore through a Qualified Institutional Placement to strengthen balance sheet and fund expansion. One of the plants underwent scheduled maintenance shutdown in May, which temporarily affected production. Risks Earnings volatility and margin compression due to raw material cost fluctuations. Stock valuations remain high despite weaker profitability. Heavy dependence on global demand trends and export markets. Opportunities Strong demand potential from the global “China+1” shift in chemicals sourcing. Expansion in specialty and value-added chemicals could improve margins. Long-term prospects supported by applications in pharma and agro sectors.

See More

🧪 Laxmi Organic Industries Ltd. – Possible Bottom Formation & Reversal

🔹 Price Action Current price: ₹231.51 (+9.95%). Stock has been consolidating in a Darvas Box range (₹187–₹270) for over a year. Recently bounced sharply from ₹187 support zone with strong volume. Price is attempting to break out of the box → early signs of bottom formation. 🔹 Technical Observations RSI Bullish Divergence: Price made equal/lower lows, RSI made higher lows → momentum shift in progress. Volume Confirmation: Strong green candle supported by rising volume → institutional buying likely. Darvas Box Resistance: Immediate hurdle at ₹228–₹235, followed by major resistance at ₹270. If sustained above ₹270, this will confirm a medium-term trend reversal. 🔹 Key Levels Support: ₹187 → ₹160 (bottom of the box). Resistance: ₹235 (current breakout zone), ₹270 (major breakout level). Upside Targets on Breakout: ₹300 → ₹340 → ₹380. 🔹 Indicators RSI ~61: Strengthening, holding above 50 for the first time in months. Momentum: Bullish divergence suggests accumulation phase ending. Trendline Breaks: Multiple downtrend lines have been violated, showing reversal strength. 🔹 Strength & Risk ✅ Bullish RSI divergence + volume support. ✅ Long consolidation, strong base near ₹187. ❌ Resistance at ₹270 is crucial; failure here may extend consolidation. ❌ Broader chemical sector still facing mixed trend, so momentum may take time. 🔹 Outlook Short Term: Likely to retest ₹235–₹240. If cleared with volume, ₹270 will be tested soon. Medium Term: Bullish reversal confirmed only above ₹270; then ₹300+ becomes possible. Strategy: Accumulate near ₹200–₹210 support with strict stop below ₹185; add on breakout above ₹270. 📢 Disclaimer: Educational analysis, not investment advice. 🧑‍💼 Rajneesh Sharma – SEBI Registered Research Analyst (INH000020332).

See More

Chemical Stocks continue to outperform the market

In the last 11 months, the chemicals and petrochemicals sector has been a top destination for foreign portfolio investment (FPI) in Indian equities. It is the only sector to see uninterrupted FPI inflows, including $130 million in July and $278 million in June, according to NSDL data. Overall Inflows: While the chemicals and petrochemicals sector saw steady inflows, FPIs were net sellers in the overall Indian equity market in July. Company Performance: Chemical and petrochemical stocks have handsomely rewarded investors. In the year leading up to August 12, Indochem topped the list with 308% gains, followed by Camlin Fine Sciences (115%) and Kesar Petroproducts (63%). However, most chemical stocks have faced significant pressure in the past month due to potential US tariffs. Companies like

, , and saw declines, with some, such as and , experiencing drops of 15% or more. Outliers: A few companies, including Bliss GVS Pharma (13%) and (19%), defied this trend and posted gains. US Tariffs: Experts are cautious about the sector's momentum, citing the threat of punitive US tariffs. The hope that pharma and specialty healthcare would be exempt from these tariffs initially boosted the sector, but this optimism may be short-lived. Competitive Landscape: Analysts like Swarnendu Bhushan of PL Capital believe a rebound is not imminent, as margins are shrinking and prices are struggling to recover due to Chinese overcapacity and dumping. Export and Pricing Pressure: Icra notes that about 60% of India's agrochemicals are exported, with the US accounting for 18%. Tariffs and a narrowing price gap with China could increase pricing pressure on Indian exports. While valuations remain high for most stocks, there are still "decently priced pockets" that could deliver solid returns for investors.

See More